| Bioactivity | (Rac)-16:0 PI(5)P-d5 diammonium is deuterium labeled (Rac)-16:0 PI(5)P diammonium[1]. |
| Invitro | 氢、碳和其他元素的稳定重同位素已被加入药物分子中，主要用作药物开发过程中定量的示踪剂。氘化因其可能影响药物的药代动力学和代谢特征而受到关注[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> (Rac)-16:0 PI(5)P-d5 diammonium 相关抗体: |
| Formula | C41H81D5N2O16P2 |
| Molar Mass | 930.10 |
| Appearance | 固体 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. |